** ASX-listed shares of Australia's AVITA Medical AVH.AX RCEL.O rise as much as 7.9% to A$4.11
** Stock set for strongest trading session since early Nov and hits highest since Dec. 12
** Co says U.S. Food and Drug Administration granted approval for its Recell Go mini product
** The product is a mini disposable cartridge designed to treat smaller wounds
** Stock had fallen 11.2% this year, as of last close
(Reporting by Rishav Chatterjee in Bengaluru)
((Rishav.Chatterjee@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。